genedrive (LON:GDR) Stock Passes Below Fifty Day Moving Average – What’s Next?

genedrive plc (LON:GDRGet Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 2.21 ($0.03) and traded as low as GBX 2 ($0.03). genedrive shares last traded at GBX 2 ($0.03), with a volume of 3,627,680 shares traded.

genedrive Price Performance

The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35. The firm has a market cap of £11.36 million, a price-to-earnings ratio of -0.56 and a beta of -0.04. The company’s 50-day moving average is GBX 2.21 and its 200-day moving average is GBX 2.39.

genedrive (LON:GDRGet Free Report) last released its quarterly earnings results on Friday, November 29th. The company reported GBX (4.70) (($0.06)) earnings per share (EPS) for the quarter. genedrive had a negative net margin of 1,412.18% and a negative return on equity of 191.22%. Equities research analysts predict that genedrive plc will post 209.9999867 earnings per share for the current year.

Insider Activity at genedrive

In related news, insider Ian David Gilham bought 225,000 shares of the stock in a transaction that occurred on Friday, December 20th. The shares were acquired at an average price of GBX 2 ($0.03) per share, with a total value of £4,500 ($5,663.94). 14.75% of the stock is owned by company insiders.

About genedrive

(Get Free Report)

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.

Featured Stories

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.